Alzinova
0.60 SEK
-0.66 %
Less than 1K followers
ALZ
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.66 %
-2.44 %
-27.62 %
-27.62 %
-46.52 %
-74.14 %
-76.56 %
-89.65 %
-91.63 %
Alzinova is a biotechnology company. The company specializes in the therapeutic treatment of Alzheimer's and conducts research and development of peptides that are further developed as vaccines. In addition, the company also develops various research tools within the field of work. The largest operations are found in the Nordic market. The company was founded in 2011 and has its headquarters in Mölndal.
Read moreMarket cap
92.98M SEK
Turnover
171.81K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
14/5
2026
Interim report Q1'26
26/5
2026
General meeting '26
20/8
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
Redeye: Alzinova (Q4 Review): Extended runway, still focus on deal
Alzinova offentliggör bokslutskommuniké för 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools